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Primary Immunodeficiencies (PID) are defects of the
immune system that cause increased susceptibility to
infections that are chronic, persistent, recurring, debili-
tating, and often fatal. There are more than 150 PID dis-
eases, which affect more than 10 million people
worldwide.
PID are often manageable, if properly evaluated and
treated. However, awareness of these diseases is low
amongst both primary care physicians and the general
public. As a result, many patients are left undiagnosed.
Delayed diagnosis and insufficient treatment leads to
increased morbidity, mortality, and inflated medical
costs, in addition to a life of chronic illness and
suffering.
The Jeffrey Modell Foundation (JMF) was established
in 1987 in memory of our son, Jeffrey, who died at the
age of 15 after struggling with a PID. JMF’s mission is
to assure early and precise diagnosis, meaningful treat-
ments, and ultimately, cures of the ever increasing
known PID diseases.
JMF initiated a Physician Education and Public Aware-
ness Campaign to create greater awareness and encou-
rage the earliest possible diagnose and precise
treatment. This global campaign has had extraordinary
results. Expert physicians from the Jeffrey Modell Cen-
tres Network of 72 Diagnostic and Research Centres
and more than 196 Referral Centres worldwide have
reported annual increases of more than 25% in the
numbers of patients referred, patients followed, and
patients identified with a specific PID. To date, more
than 414 physicians from 176 teaching hospitals in 51
countries participate in the Jeffrey Modell Centres
Network.
Nearly half of the Jeffrey Modell Diagnostic, Research
and Referral Centres are located in Western, Central,
and Eastern Europe. This European Network of Diag-
nostic Centres promotes improvements in the standard
of care for patients with PID by fostering collaboration,
measuring outcomes, sharing data, and serving the
patients, families and caregivers of those affected by
PID, and serves as a successful model for other diseases.
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